Precision Proteomics

At the Precision Proteomics Center in Davos, we develop and apply cutting-edge mass spectrometry (MS)-based technologies for the proteome and glycoproteome analyses of clinical samples, including body fluids, tissues, and cells. In collaboration with clinicians and biobanks, we utilize our technologies across a wide range of applications, including cancer, autoimmune disorders, and allergies. Through data-driven approaches, we aim to identify biomarkers and disease mechanisms, contributing to the development of the next generation of personalized treatments.